BTIG analyst Julian Harrison reiterated a Buy rating and $70.00 price target on Spyre (NASDAQ: SYRE).The analyst comments "Royalty Pharma ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE